Effects of 3′-hydroxyfarrerol (IdB 1031), a novel flavonoid agent, on phagocyte products

Federica Meloni, Piercarla Ballabio, Marina Gorrini, Mara De Amici, Carlo Marena, Salvatore Malandrino, Maurizio Luisetti

Research output: Contribution to journalArticle

Abstract

The novel flavonoid compound 3′-hydroxyfarrerol (IdB 1031) was tested in a number of in vitro experiments in order to ascertain its effects on some functions and products of human phagocytes. We found that IdB 1031 did not depress neutrophil phagocytosis and chemotaxis, whereas at a concentration of 10-4 M it significantly (p}i 200 μm). Finally, IdB 1031 at the concentration of 10-5 M significantly reduced the release of tumor necrosis factor-α and interleukin-8 from monocytes (p <0.05). We conclude that, in spite of the moderate activity displayed by IdB 1031, these findings add to our current knowledge on the spectrum of the antiinflammatory activities of flavonoids.

Original languageEnglish
Pages (from-to)689-699
Number of pages11
JournalInflammation
Volume19
Issue number6
DOIs
Publication statusPublished - Dec 1995

Fingerprint

Phagocytes
Flavonoids
Chemotaxis
Interleukin-8
Phagocytosis
Monocytes
Neutrophils
Anti-Inflammatory Agents
Tumor Necrosis Factor-alpha
IdB 1031

ASJC Scopus subject areas

  • Medicine(all)
  • Immunology
  • Cell Biology

Cite this

Effects of 3′-hydroxyfarrerol (IdB 1031), a novel flavonoid agent, on phagocyte products. / Meloni, Federica; Ballabio, Piercarla; Gorrini, Marina; De Amici, Mara; Marena, Carlo; Malandrino, Salvatore; Luisetti, Maurizio.

In: Inflammation, Vol. 19, No. 6, 12.1995, p. 689-699.

Research output: Contribution to journalArticle

Meloni, Federica ; Ballabio, Piercarla ; Gorrini, Marina ; De Amici, Mara ; Marena, Carlo ; Malandrino, Salvatore ; Luisetti, Maurizio. / Effects of 3′-hydroxyfarrerol (IdB 1031), a novel flavonoid agent, on phagocyte products. In: Inflammation. 1995 ; Vol. 19, No. 6. pp. 689-699.
@article{44b7a353652c4339afa88d1d1c95ebd6,
title = "Effects of 3′-hydroxyfarrerol (IdB 1031), a novel flavonoid agent, on phagocyte products",
abstract = "The novel flavonoid compound 3′-hydroxyfarrerol (IdB 1031) was tested in a number of in vitro experiments in order to ascertain its effects on some functions and products of human phagocytes. We found that IdB 1031 did not depress neutrophil phagocytosis and chemotaxis, whereas at a concentration of 10-4 M it significantly (p}i 200 μm). Finally, IdB 1031 at the concentration of 10-5 M significantly reduced the release of tumor necrosis factor-α and interleukin-8 from monocytes (p <0.05). We conclude that, in spite of the moderate activity displayed by IdB 1031, these findings add to our current knowledge on the spectrum of the antiinflammatory activities of flavonoids.",
author = "Federica Meloni and Piercarla Ballabio and Marina Gorrini and {De Amici}, Mara and Carlo Marena and Salvatore Malandrino and Maurizio Luisetti",
year = "1995",
month = "12",
doi = "10.1007/BF01534572",
language = "English",
volume = "19",
pages = "689--699",
journal = "Inflammation",
issn = "0360-3997",
publisher = "Springer New York",
number = "6",

}

TY - JOUR

T1 - Effects of 3′-hydroxyfarrerol (IdB 1031), a novel flavonoid agent, on phagocyte products

AU - Meloni, Federica

AU - Ballabio, Piercarla

AU - Gorrini, Marina

AU - De Amici, Mara

AU - Marena, Carlo

AU - Malandrino, Salvatore

AU - Luisetti, Maurizio

PY - 1995/12

Y1 - 1995/12

N2 - The novel flavonoid compound 3′-hydroxyfarrerol (IdB 1031) was tested in a number of in vitro experiments in order to ascertain its effects on some functions and products of human phagocytes. We found that IdB 1031 did not depress neutrophil phagocytosis and chemotaxis, whereas at a concentration of 10-4 M it significantly (p}i 200 μm). Finally, IdB 1031 at the concentration of 10-5 M significantly reduced the release of tumor necrosis factor-α and interleukin-8 from monocytes (p <0.05). We conclude that, in spite of the moderate activity displayed by IdB 1031, these findings add to our current knowledge on the spectrum of the antiinflammatory activities of flavonoids.

AB - The novel flavonoid compound 3′-hydroxyfarrerol (IdB 1031) was tested in a number of in vitro experiments in order to ascertain its effects on some functions and products of human phagocytes. We found that IdB 1031 did not depress neutrophil phagocytosis and chemotaxis, whereas at a concentration of 10-4 M it significantly (p}i 200 μm). Finally, IdB 1031 at the concentration of 10-5 M significantly reduced the release of tumor necrosis factor-α and interleukin-8 from monocytes (p <0.05). We conclude that, in spite of the moderate activity displayed by IdB 1031, these findings add to our current knowledge on the spectrum of the antiinflammatory activities of flavonoids.

UR - http://www.scopus.com/inward/record.url?scp=0028785977&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028785977&partnerID=8YFLogxK

U2 - 10.1007/BF01534572

DO - 10.1007/BF01534572

M3 - Article

C2 - 8595935

AN - SCOPUS:0028785977

VL - 19

SP - 689

EP - 699

JO - Inflammation

JF - Inflammation

SN - 0360-3997

IS - 6

ER -